Skip to main content

The MedTech Dive Outlook on 2022

The pandemic continues to disrupt the medical device industry early in 2022, as COVID-19 testing demand remains strong and nonemergent procedures are postponed. In this series, we look at the risks, challenges and opportunities ahead.

included in this trendline
  • Key FDA topics for medtechs in 2022
  • 4 key trends for procedure-reliant medtechs
  • Diagnostics makers ride omicron surge in COVID-19 test demand. But for how long in 2022?
Note: Trendlines are a premium product, available to subscribers of our free newsletters. Access this Trendline by signing up for the MedTech Dive newsletter or enter your information if you're already subscribed.
Produced by our team of award-winning journalists, the MedTech Dive Outlook for 2022 can help you and your organization navigate the uncertain road ahead in your market.
Davide Savenije Editor-in-Chief at Industry Dive.